Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model

Gynecologic Oncology

Volumn 119, Issue 3, 2010, Pages 594-600

  Van Calsteren, K ^a   Verbesselt, R ^a   Beijnen, J ^b   Devlieger, R ^a   De Catte, L ^a   Chai, D C ^c   Van Bree, R ^a   Heyns, L ^a   De Hoon, J ^a   Amant, F ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c INSTITUTE OF PRIMATE RESEARCH   (Kenya)

Author keywords

Anthracyclines; Baboon; Chemotherapy; Cyclophosphamide; Transplacental transfer; Vinblastine

Indexed keywords

4 HYDROXYCYCLOPHOSPHAMIDE; ANTHRACYCLINE; BLEOMIN; BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; FARMARUBICINE; FLUOROURACIL; METHYLPREDNISOLONE; UNCLASSIFIED DRUG; VINBLASTINE;

AMNION FLUID; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BABOON; BLOOD SAMPLING; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG ABSORPTION; DRUG TRANSPORT; DRUG URINE LEVEL; FEMALE; FETUS BLOOD; FETUS BLOOD SAMPLING; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATERNAL BLOOD; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL;

AMNIOTIC FLUID; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; FEMALE; FETAL BLOOD; FLUOROURACIL; MASS SPECTROMETRY; PAPIO; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; VINBLASTINE;

EID: 78149357716     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.08.019     Document Type: Article

References (34)

1. K. Van Calsteren, L. Heyns, F. De Smet, L. Van Eycken, Gziri M. Mhallem, and W. Van Gemert Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes J Clin Oncol 28 2010 683 689
2. H. Stensheim, B. Moller, T. van Dijk, and S.D. Fossa Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study J Clin Oncol 27 2009 45 51
3. E. Cardonick, R. Dougherty, G. Grana, D. Gilmandyar, S. Ghaffar, and A. Usmani Breast cancer during pregnancy: maternal and fetal outcomes Cancer J 16 2010 76 82
4. E. Cardonick, and A. Iacobucci Use of chemotherapy during human pregnancy Lancet Oncol 5 2004 283 291
5. V.J. Wiebe, and P.E. Sipila Pharmacology of antineoplastic agents in pregnancy Crit Rev Oncol Hematol 16 1994 75 112
6. D. Pereg, G. Koren, and M. Lishner Cancer in pregnancy: gaps, challenges and solutions Cancer Treat Rev 34 2008 302 312
7. A. Aviles, and N. Neri Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero Clin Lymphoma 2 2001 173 177
8. K.M. Hahn, P.H. Johnson, N. Gordon, H. Kuerer, L. Middleton, and M. Ramirez Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero Cancer 107 2006 1219 1226
9. J. Roboz, N. Gleicher, K. Wu, P. Chanihian, T. Kerenyi, and J. Holland Does doxorubicin cross the placenta? Lancet 2 1979 1382 1383
10. M. D'Incalci, M. Broggini, M. Buscaglia, and G. Pardi Transplacental passage of doxorubicin Lancet 1 1983 75
11. G.I. Karp, P. von Oeyen, F. Valone, V.K. Khetarpal, M. Israel, and R.J. Mayer Doxorubicin in pregnancy: possible transplacental passage Cancer Treat Rep 67 1983 773 777
12. C.L. Murray, J.A. Reichert, J. Anderson, and L.B. Twiggs Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report JAMA 252 1984 2607 2608
13. S. Barni, A. Ardizzoia, G. Zanetta, E. Strocchi, P. Lissoni, and G. Tancini Weekly doxorubicin chemotherapy for breast cancer in pregnancy. A case report Tumori 78 1992 349 350
14. N. Germann, F. Goffinet, and F. Goldwasser Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients Ann Oncol 15 2004 146 150
15. Van Calsteren K., Verbesselt R., Van Bree R., Heyns L., de Bruijn E., de Hoon J. et al. Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model. Reprod Sci. doi:10.1177/ 1933719110379650.
16. C. Liao, J. Wei, Q. Li, L. Li, J. Li, and D. Li Efficacy and safety of cordocentesis for prenatal diagnosis Int J Gynaecol Obstet 93 2006 13 17
17. K. Van Calsteren, R. Devlieger, L. De Catte, T. D'Hooghe, D.C. Chai, and J.M. Mwenda Feasibility of ultrasound-guided percutaneous samplings in the pregnant baboon: a model for studies on transplacental transport Reprod Sci 16 2009 280 285
18. A.M. Carter Animal models of human placentation-a review Placenta 28 Suppl A 2007 S41 S47
19. M. Garland, H.H. Szeto, S.S. Daniel, P.J. Tropper, M.M. Myers, and R.I. Stark Placental transfer and fetal metabolism of zidovudine in the baboon Pediatr Res 44 1998 47 53
20. K. Van Calsteren, L. De Catte, R. Devlieger, D.C. Chai, and F. Amant Sonographic biometrical normograms and estimation of fetal weight in the baboon (Papio anubis) J Med Primatol 38 2009 321 327
21. M. Trudeau, F. Charbonneau, K. Gelmon, K. Laing, J. Latreille, and J. Mackey Selection of adjuvant chemotherapy for treatment of node-positive breast cancer Lancet Oncol 6 2005 886 898
22. E. Iannitto, V. Minardi, P.G. Gobbi, G. Calvaruso, C. Tripodo, and L. Marcheselli Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial Clin Lymphoma Myeloma 9 2009 138 144
23. A.G. Hendrickx, and Kraemer D.C. Reproduction A.G. Hendrickx, Embryology of the baboon 1971 University of Chicago Press Chicago 22 50
24. C. Ekhart, A. Gebretensae, H. Rosing, S. Rodenhuis, J.H. Beijnen, and A.D. Huitema Simultaneous quantification of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC-MS/MS) J Chromatogr B Analyt Technol Biomed Life Sci 854 2007 345 349
25. P. Grohard, J.P. Akbaraly, M.C. Saux, S. Gimenez, J. Robert, and A. Brachet-Liermain Transplacental passage of doxorubicin J Gynecol Obstet Biol Reprod (Paris) 18 1989 595 600
26. B. Gaillard, J.J. Leng, J. Grellet, D. Ducint, and M.C. Saux Transplacental passage of epirubicin J Gynecol Obstet Biol Reprod (Paris) 24 1995 63 68
27. P.A. Johansson, K.M. Dziegielewska, S.A. Liddelow, and N.R. Saunders The blood-CSF barrier explained: when development is not immaturity Bioessays 30 2008 237 248
28. S.E. Lipshultz, S.D. Colan, R.D. Gelber, A.R. Perez-Atayde, S.E. Sallan, and S.P. Sanders Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood N Engl J Med 324 1991 808 815
29. M. Meyer-Wittkopf, H. Barth, G. Emons, and S. Schmidt Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature Ultrasound Obstet Gynecol 18 2001 62 66
30. A. Aviles, N. Neri, and M.J. Nambo Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy Ann Oncol 17 2006 286 288
31. M.R. Syme, J.W. Paxton, and J.A. Keelan Drug transfer and metabolism by the human placenta Clin Pharmacokinet 43 2004 487 514
32. J.Z. Fuks, M.J. Egorin, J. Aisner, S.S. Ostrow, M.E. Klein, and N.R. Bachur Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics Cancer Chemother Pharmacol 6 1981 117 120
33. D.K. James, P.J. Steer, High Risk Pregnancy: Management Options 2003 W.B Saunders Philadelphia, USA
34. C. Gedeon, and G. Koren Designing pregnancy centered medications: drugs which do not cross the human placenta Placenta 27 2006 861 868